"Risk averseness will remain in the market for some time and to that extent, pharma is the only sector which did not perform as well in the overall up move. So to that extent, the ownership also and some of the companies have been giving decent numbers. Largecap pharma could actually outperform and that is something which should be the trade for a few weeks. " | Subscribe To Our Free Newsletter |
